Kronos Bio (KRON) Stock Statistics & Valuation Metrics

Kronos Bio has a market cap or net worth of $53.65M. The enterprise value is $46.16M.

Kronos Bio has 60,969,000 shares outstanding. The number of shares has decreased by -2.65% in one year.

Kronos Bio’s return on equity (ROE) is -0.98 and return on invested capital (ROIC) is -82.58%.

The current PE Ratio of {name} is {pe}. {name}’s PEG ratio is {priceToEarningsGrowthRatio}.

In the last 12 months, Kronos Bio had revenue of 9.85M and earned -86.08M in profits. Earnings per share was -1.43.

In the last 12 months, operating cash flow was -54.38M and capital expenditures 3.00K, giving a free cash flow of -54.38M billion.

Kronos Bio pays an annual dividend of ―, resulting in a dividend yield of ―

Kronos Bio upcoming earnings date is ―, ―.

Kronos Bio as a current ratio of 7.54, with Debt / Equity ratio of 12.72%

In the past 12 months, Kronos Bio has paid 0.00 in taxes.

Kronos Bio EV to EBITDA ratio is 0.04, with an EV/FCF ratio of 0.04.

Kronos Bio has $99.73M in cash and marketable securities with $24.09M in debt, giving a net cash position of -$75.64M billion.

Gross margin is 0.00%, with operating margin of -943.21%, and net profit margin of -874.08%.

The average price target for Kronos Bio is $1.00, which is 11.43% higher than the current price. The consensus rating is Hold